Ocular Therapeutix: Advancing Retinal Disease Treatment: Exploring OTX-TKI’s Potential to Extend Treatment Durability

Location: Amphitheatre Havane
Date & Time: Saturday, 6th September, 10:15 – 11:15 CEST
Chairperson(s): P. Schlottmann, ARGENTINA

Speakers:

Presentations:

A. Loewenstein, ISRAEL

10:15  Drug Delivery Approaches and TKI Development for Retinal Diseases

P. Lanzetta, ITALY

10:27  Phase 1 Study Results of OTX-TKI

S. Sivaprasad, UK

10:39  SOL-1 and SOL-R: Pivotal Phase 3 Trials Evaluating OTX-TKI for Wet AMD

All Speakers 

10:51  Panel Discussion

Back to Main Programme